These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22073373)

  • 21. ZNF9 activation of IRES-mediated translation of the human ODC mRNA is decreased in myotonic dystrophy type 2.
    Sammons MA; Antons AK; Bendjennat M; Udd B; Krahe R; Link AJ
    PLoS One; 2010 Feb; 5(2):e9301. PubMed ID: 20174632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of MTMR1 expression and correlation with muscle pathological features in juvenile/adult onset myotonic dystrophy type 1 (DM1) and in myotonic dystrophy type 2 (DM2).
    Santoro M; Modoni A; Masciullo M; Gidaro T; Broccolini A; Ricci E; Tonali PA; Silvestri G
    Exp Mol Pathol; 2010 Oct; 89(2):158-68. PubMed ID: 20685272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progression of muscle histopathology but not of spliceopathy in myotonic dystrophy type 2.
    Cardani R; Giagnacovo M; Rossi G; Renna LV; Bugiardini E; Pizzamiglio C; Botta A; Meola G
    Neuromuscul Disord; 2014 Dec; 24(12):1042-53. PubMed ID: 25139674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct pathological signatures in human cellular models of myotonic dystrophy subtypes.
    Kim EY; Barefield DY; Vo AH; Gacita AM; Schuster EJ; Wyatt EJ; Davis JL; Dong B; Sun C; Page P; Dellefave-Castillo L; Demonbreun A; Zhang HF; McNally EM
    JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30730308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2.
    Ranum LP; Day JW
    Curr Neurol Neurosci Rep; 2002 Sep; 2(5):465-70. PubMed ID: 12169228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ClC1 chloride channel in myotonic dystrophy type 2 and ClC1 splicing in vitro.
    Ursu SF; Alekov A; Mao NH; Jurkat-Rott K
    Acta Myol; 2012 Oct; 31(2):144-53. PubMed ID: 23097607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect.
    Bachinski LL; Udd B; Meola G; Sansone V; Bassez G; Eymard B; Thornton CA; Moxley RT; Harper PS; Rogers MT; Jurkat-Rott K; Lehmann-Horn F; Wieser T; Gamez J; Navarro C; Bottani A; Kohler A; Shriver MD; Sallinen R; Wessman M; Zhang S; Wright FA; Krahe R
    Am J Hum Genet; 2003 Oct; 73(4):835-48. PubMed ID: 12970845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular Senescence and Aging in Myotonic Dystrophy.
    Hasuike Y; Mochizuki H; Nakamori M
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myotonic dystrophy type 2 and related myotonic disorders.
    Meola G; Moxley RT
    J Neurol; 2004 Oct; 251(10):1173-82. PubMed ID: 15503094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2.
    Kamsteeg EJ; Kress W; Catalli C; Hertz JM; Witsch-Baumgartner M; Buckley MF; van Engelen BG; Schwartz M; Scheffer H
    Eur J Hum Genet; 2012 Dec; 20(12):1203-8. PubMed ID: 22643181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nuclear ribonucleoprotein-containing foci increase in size in non-dividing cells from patients with myotonic dystrophy type 2.
    Giagnacovo M; Malatesta M; Cardani R; Meola G; Pellicciari C
    Histochem Cell Biol; 2012 Oct; 138(4):699-707. PubMed ID: 22706481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skeletal muscle involvement in myotonic dystrophy type 2. A comparative muscle ultrasound study.
    Tieleman AA; Vinke A; van Alfen N; van Dijk JP; Pillen S; van Engelen BG
    Neuromuscul Disord; 2012 Jun; 22(6):492-9. PubMed ID: 22414627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myotonic dystrophy types 1 and 2.
    Ashizawa T; Sarkar PS
    Handb Clin Neurol; 2011; 101():193-237. PubMed ID: 21496635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of the [CCTG]n repeat expansion on ZNF9 expression in myotonic dystrophy type II (DM2).
    Botta A; Caldarola S; Vallo L; Bonifazi E; Fruci D; Gullotta F; Massa R; Novelli G; Loreni F
    Biochim Biophys Acta; 2006 Mar; 1762(3):329-34. PubMed ID: 16376058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Most expression and splicing changes in myotonic dystrophy type 1 and type 2 skeletal muscle are shared with other muscular dystrophies.
    Bachinski LL; Baggerly KA; Neubauer VL; Nixon TJ; Raheem O; Sirito M; Unruh AK; Zhang J; Nagarajan L; Timchenko LT; Bassez G; Eymard B; Gamez J; Ashizawa T; Mendell JR; Udd B; Krahe R
    Neuromuscul Disord; 2014 Mar; 24(3):227-40. PubMed ID: 24332166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome wide identification of aberrant alternative splicing events in myotonic dystrophy type 2.
    Perfetti A; Greco S; Fasanaro P; Bugiardini E; Cardani R; Garcia-Manteiga JM; Riba M; Cittaro D; Stupka E; Meola G; Martelli F
    PLoS One; 2014; 9(4):e93983. PubMed ID: 24722564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative transcriptional and biochemical studies in muscle of myotonic dystrophies (DM1 and DM2).
    Salvatori S; Furlan S; Fanin M; Picard A; Pastorello E; Romeo V; Trevisan CP; Angelini C
    Neurol Sci; 2009 Jun; 30(3):185-92. PubMed ID: 19326042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deregulated microRNAs in myotonic dystrophy type 2.
    Greco S; Perfetti A; Fasanaro P; Cardani R; Capogrossi MC; Meola G; Martelli F
    PLoS One; 2012; 7(6):e39732. PubMed ID: 22768114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Large CTG repeats trigger p16-dependent premature senescence in myotonic dystrophy type 1 muscle precursor cells.
    Bigot A; Klein AF; Gasnier E; Jacquemin V; Ravassard P; Butler-Browne G; Mouly V; Furling D
    Am J Pathol; 2009 Apr; 174(4):1435-42. PubMed ID: 19246640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Muscle weakness in myotonic dystrophy associated with misregulated splicing and altered gating of Ca(V)1.1 calcium channel.
    Tang ZZ; Yarotskyy V; Wei L; Sobczak K; Nakamori M; Eichinger K; Moxley RT; Dirksen RT; Thornton CA
    Hum Mol Genet; 2012 Mar; 21(6):1312-24. PubMed ID: 22140091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.